Edwards Lifesciences (EW) EBT Margin Growth (1y) (2010 - 2026)
Edwards Lifesciences (EW) EBT Margin Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.71 Bn | 194.11 Bn | 7.27 Bn | -719.00 |
| 2 | Stryker | 129.50 Bn | 126.03 Bn | 4.50 Bn | 687.00 |
| 3 | Medtronic | 119.85 Bn | 110.63 Bn | 6.41 Bn | 458.00 |
| 4 | Boston Scientific | 73.79 Bn | 73.25 Bn | 3.85 Bn | 88.00 |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 374.00 |
| 6 | Dexcom | 34.58 Bn | 32.64 Bn | 830.00 Mn | 343.00 |
| 7 | GE HealthCare Technologies | 34.14 Bn | 32.03 Bn | 2.18 Bn | 84.00 |
| 8 | Koninklijke Philips | 26.45 Bn | 23.13 Bn | 4.55 Bn | -126.00 |
| 9 | Steris | 23.23 Bn | 22.74 Bn | 684.20 Mn | 165.00 |
| 10 | Zimmer Biomet Holdings | 19.35 Bn | 18.94 Bn | 1.54 Bn | 91.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 374.00 |
| Mar 31, 2026 | -287.00 |
| Dec 31, 2025 | -2,239.00 |
| Sep 30, 2025 | -731.00 |
| Jun 30, 2025 | -192.00 |
| Mar 31, 2025 | 280.00 |
| Dec 31, 2024 | -85.00 |
| Sep 30, 2024 | -143.00 |
| Jun 30, 2024 | 653.00 |
| Mar 31, 2024 | -473.00 |
| Dec 31, 2023 | -2,018.00 |
| Sep 30, 2023 | 29.00 |
| Jun 30, 2023 | -1,231.00 |
| Mar 31, 2023 | 12.00 |
| Dec 31, 2022 | 2,087.00 |
| Sep 30, 2022 | 104.00 |
| Jun 30, 2022 | -582.00 |
| Mar 31, 2022 | 52.00 |
| Dec 31, 2021 | -158.00 |
| Sep 30, 2021 | -210.00 |